Dashboard
Financial statements
DHR

Company financials

Danaher Corporation

Health Care Life Sciences Tools & Services Washington, D.C. Last filing Feb 24, 2026 · FY2025
Revenue FY2025
$24.6B
3y CAGR -2.7% P10
Net income FY2025
$3.6B
Net margin +14.7% P63
Total assets FY2025
$83.5B
ROA +4.3% P36
Operating cash flow FY2025
$6.4B
FCF margin +21.4% P75
19 yrs · FY2007–FY2025 8 filed · 1 derived · 0 blank

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

24 accounts · 1 year
Total assets $83.5B
Total liabilities ~$30.9B
Shareholders equity $52.5B
Account 2025 Trend
Assets
Cash and Cash Equivalents 18.8%
Accounts Receivable 15.9%
Inventory 10.1%
Prepaid Expenses 7.1%
Total Current Assets 51.9%
Property,Plant and Equipment 22.5%
Goodwill 175.6%
Intangible Assets 72.5%
Other Noncurrent Assets 17.1%
Total Assets 339.7%
Liabilities
Accounts Payable 7.5%
Accrued Liabilities 20.2%
Current Portion of Long Term Debt 0.0%
Total Current Liabilities 27.7%
Long Term Debt 75.0%
Other Noncurrent Liabilities 23.2%
Equity
Common Stock 0.0%
Additional Paid In Capital 70.0%
Retained Earnings 190.9%
Treasury Stock 46.2%
Accumulated Other Comprehensive Income -0.8%
Total Stockholders Equity 213.8%
Noncontrolling Interest 0.0%
Total Liabilitiesand Equity 339.7%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year
Ratio 2025
Profitability
Gross margin +59.1%
Operating margin +19.1%
Net margin +14.7%
FCF margin +21.4%
Growth
Revenue CAGR (3y) -2.7%
Returns
ROE +6.9%
ROA +4.3%
ROIC +6.0%
Liquidity
Current ratio 1.87x
Quick ratio 1.25x
Leverage
D/E 0.59x
Interest coverage 17.70x
Efficiency
Asset turnover 0.29x
Cash conversion cycle +82d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds DHR to your watchlist.